Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60.
暂无分享,去创建一个
H. Iba | Y. Kuzuu | I. Takahashi | T. Tamaoki | H. Nakano | E. Kobayashi
[1] A. Ullrich,et al. The complete primary structure of protein kinase C--the major phorbol ester receptor. , 1986, Science.
[2] J. Ishida,et al. A specific inhibitor for tyrosine protein kinase from Pseudomonas. , 1986, The Journal of antibiotics.
[3] T. Tamaoki,et al. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. , 1986, Biochemical and biophysical research communications.
[4] H. Iba,et al. Lack of induction of neuroretinal cell proliferation by Rous sarcoma virus variants that carry the c-src gene , 1985, Molecular and cellular biology.
[5] F. Cross,et al. Low level of cellular protein phosphorylation by nontransforming overproduced p60c-src , 1985, Molecular and cellular biology.
[6] M. Perry,et al. P1,P4-Di(adenosine-5')tetraphosphate inhibits phosphorylation of immunoglobulin G by Rous sarcoma virus pp60src. , 1983, The Journal of biological chemistry.
[7] H. Hanafusa,et al. Role of p60src kinase activity in the induction of neuroretinal cell proliferation by rous sarcoma virus , 1982, Journal of virology.
[8] I. Pastan,et al. Inhibition of the transformation-specific kinase in ASV-transformed cells by N-α-tosyl-L-lysyl chloromethyl ketone , 1979, Cell.
[9] S Omura,et al. A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. , 1977, The Journal of antibiotics.
[10] E. Rapaport,et al. Presence of diadenosine 5',5''' -P1, P4-tetraphosphate (Ap4A) in mamalian cells in levels varying widely with proliferative activity of the tissue: a possible positive "pleiotypic activator". , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Barbacid,et al. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences , 1986, Nature.
[12] M. Imoto,et al. Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3. , 1986, The Journal of antibiotics.